(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE
![(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE Structure](CAS/GIF/213843-90-4.gif)
- CAS No.
- 213843-90-4
- Chemical Name:
- (3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE
- Synonyms
- (R,R)-TADDOL-PNMe2;(3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET&;(3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxapho;(3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph;(3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphe;(3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepi;(3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine;(3aR,8aR)-Tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine;1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine, tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-, (3aR,8aR)-;(3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine
- CBNumber:
- CB7103928
- Molecular Formula:
- C33H34NO4P
- Molecular Weight:
- 539.6
- MOL File:
- 213843-90-4.mol
- MSDS File:
- SDS
- Modify Date:
- 2023/4/23 13:52:06
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE Properties
Melting point | 218-221 °C |
---|---|
Boiling point | 569.8±50.0 °C(Predicted) |
alpha | -159° (c 1.66, CHCl3) |
storage temp. | under inert gas (nitrogen or Argon) at 2-8°C |
pka | 2.44±0.70(Predicted) |
form | Powder |
color | white |
Sensitive | moisture sensitive |
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE price More Price(2)
Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|---|
Sigma-Aldrich(India) | 665460 | (3aR,8aR)-(−)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 96% | 213843-90-4 | 100MG | ₹9320.33 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | 665460 | (3aR,8aR)-(−)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 96% | 213843-90-4 | 500MG | ₹31468.28 | 2022-06-14 | Buy |
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE Chemical Properties,Uses,Production
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE Preparation Products And Raw materials
Raw materials
Preparation Products
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE Suppliers
Global( 53)Suppliers
Supplier | Tel | Country | ProdList | Advantage | Inquiry |
---|---|---|---|---|---|
A.J Chemicals | 91-9810153283 | New Delhi, India | 6124 | 58 | Inquiry |
Career Henan Chemica Co | +86-0371-86658258 +8613203830695 | China | 30253 | 58 | Inquiry |
Shaoxin Catsyn Co., Ltd. | +undefined-0575-82040869 +86-0575-82040869; | China | 6116 | 58 | Inquiry |
Wuhan Topule Biopharmaceutical Co., Ltd | +8618327326525 | China | 8474 | 58 | Inquiry |
Aladdin Scientific | +1-+1(833)-552-7181 | United States | 57511 | 58 | Inquiry |
Amadis Chemical Company Limited | 571-89925085 | China | 131980 | 58 | Inquiry |
ABCR GmbH & CO. KG | 49 721 95061 0 | Germany | 6846 | 75 | Inquiry |
Struchem Co., Ltd. | 0512-0512-63009836 15365350169 | China | 3988 | 60 | Inquiry |
Shanghai Kaiwei Chemical Technology Co., Ltd. | 021-58461859 15821823057 | China | 49323 | 58 | Inquiry |
Bide Pharmatech Ltd. | 400-1647117 15221909166 | China | 41438 | 60 | Inquiry |
213843-90-4((3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE)Related Search:
(3aS,8aR)-2-(6-Methylpyridin-2-yl)-8,8a-dihydro-3aH-indeno[1,2-d]oxazole
(-)-2,2'-METHYLENEBIS[(3AS,8AR)-3A,8A-DIHYDRO-8H-INDENO[1,2-D]OXAZOLE]
8H-Indeno[1,2-d]oxazole, 3a,8a-dihydro-2-(6-methyl-2-pyridinyl)-, (3aR,8aS)-
(3aS,3'aS,8aR,8'a'R)-2,2'-cyclopropylidenebis[3a,8a-dihydro-8H-Indeno[1,2-d]oxazole
(3aR,8aR)-(-)-4,4,8,8-Tetrakis (3,5-di-i-propylphenyl)tetrahydro-2,2-diMethyl-6-phenyl-1,3-dioxolo[4,5-e]dioxaphosphepin
(3aR,8aR)-(-)-4,4,8,8-Tetrakis(3,5-diethylphenyl) tetrahydro-2,2-diMethyl-6-phenyl-1,3-dioxolo [4,5-e]dioxaphosphepin
PHENYLETHYL ACETAL
(-)-Taddol
DIBENZYL N,N-DIMETHYLPHOSPHORAMIDITE
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE
chevron_left
1of2
chevron_right
(3AR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TETRAPHENYL-TETRAHYDRO-[1,3]DIOXOLO[4,5-E][1,3,2]DIOXAPHOSPHEPIN-6-YL)DIMETHYLAMINE
(3aR,8AR)-(-)-(2,2-DIMETHYL-4,4,8,8-TET&
(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,min.98%
(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98%
(3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-
e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98% (3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph (11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-diMethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu (3aR,8aR)-Tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 96% (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro- [1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6- yl)dimethylamine (3aR,8aR)-(2,2- (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine (3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxapho (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro- [1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6- yl)dimethylamine,99%e.e. (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,98% (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine, tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-, (3aR,8aR)- (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphe (R,R)-TADDOL-PNMe2 (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepi 213843-90-4 C33H34NO4P C21H23O2P Asymmetric Synthesis Chiral Catalysts, Ligands, and Reagents Privileged Ligands DSM MonoPhos Phosphoramidites Phosphoramidite Chiral Catalysts, Ligands, and Reagents DSM MonoPhos Phosphoramidites Privileged Ligands and Complexes TADDOL Phos Chiral Phosphine CPN
e][1,3,2]dioxaphosphepin-6-yl)dimethylamine, min. 98% (3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosph (11aR)-(+)-10,11,12,13-Tetrahydro-5-(1,1-diMethylethyl)diindeno[7,1-de,1',7'-fg)[1.3.2] dioxaphosphocin, 97% (R)-FuP-tBu (3aR,8aR)-Tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-1,3-dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 96% (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro- [1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6- yl)dimethylamine (3aR,8aR)-(2,2- (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine (3AR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxapho (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro- [1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6- yl)dimethylamine,99%e.e. (3aR,8aR)-(-)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine,98% (3aR,8aR)-(2,2-Dimethyl-4,4,8,8-tetraphenyl-tetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-yl)dimethylamine 1,3-Dioxolo[4,5-e][1,3,2]dioxaphosphepin-6-amine, tetrahydro-N,N,2,2-tetramethyl-4,4,8,8-tetraphenyl-, (3aR,8aR)- (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphe (R,R)-TADDOL-PNMe2 (3aR,8aR)-N,N,2,2-Tetramethyl-4,4,8,8-tetraphenyltetrahydro-[1,3]dioxolo[4,5-e][1,3,2]dioxaphosphepi 213843-90-4 C33H34NO4P C21H23O2P Asymmetric Synthesis Chiral Catalysts, Ligands, and Reagents Privileged Ligands DSM MonoPhos Phosphoramidites Phosphoramidite Chiral Catalysts, Ligands, and Reagents DSM MonoPhos Phosphoramidites Privileged Ligands and Complexes TADDOL Phos Chiral Phosphine CPN